The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Parven Alvin S since 2005.
The trader's CIK number is 1231950.
At the time of the last reporting, Parven Alvin S was the Director of Alexion Pharmaceuticals, Inc.. (stock ticker symbol ALXN).
Also see all insider trading activities at Alexion Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ALXN | 0 | $0 | 23,494 | $3,221,235 | 20,166 | $1,301,553 |
| 2015 | ALXN | 0 | $0 | 895 | $159,963 | 0 | $0 |
| 2014 | ALXN | 0 | $0 | 29,747 | $5,338,737 | 27,276 | $476,755 |
| 2012 | ALXN | 140 | $11,893 | 3,115 | $286,580 | 0 | $0 |
| 2012 | ALXN | 0 | $0 | 65,450 | $5,918,629 | 63,115 | $570,600 |
| 2011 | ALXN | 0 | $0 | 10,329 | $799,316 | 9,089 | $31,374 |
| 2010 | ALXN | 0 | $0 | 24,907 | $1,556,169 | 23,783 | $159,603 |
| 2009 | ALXN | 0 | $0 | 49,000 | $2,115,620 | 45,000 | $411,450 |
| 2008 | ALXN | 0 | $0 | 18,000 | $1,451,870 | 16,000 | $924,002 |
| 2007 | ALXN | 0 | $0 | 0 | $0 | 22,000 | $1,736,350 |
| 2006 | ALXN | 0 | $0 | 0 | $0 | 6,400 | $246,316 |
| 2005 | ALXN | 1,049 | $28,050 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-06-15 | ALXN | Sale | 835 | 116.78 | 97,511 |
| 2017-01-05 | ALXN | Option Ex | 20,166 | 64.54 | 1,301,553 |
| 2017-01-05 | ALXN | Sale | 22,659 | 137.86 | 3,123,724 |
| 2015-11-02 | ALXN | Sale | 895 | 178.73 | 159,963 |
| 2014-11-11 | ALXN | Option Ex | 15,000 | 18.01 | 270,150 |
| 2014-11-11 | ALXN | Sale | 15,000 | 195.66 | 2,934,900 |
| 2014-05-13 | ALXN | Option Ex | 12,276 | 16.83 | 206,605 |
| 2014-05-13 | ALXN | Sale | 12,276 | 160.78 | 1,973,735 |
| 2014-02-11 | ALXN | Sale | 2,471 | 174.06 | 430,102 |
| 2012-03-05 | ALXN | Buy | 140 | 84.95 | 11,893 |
| 2013-03-08 | ALXN | Sale | 3,115 | 92.00 | 286,580 |
| 2012-11-19 | ALXN | Option Ex | 30,000 | 10.84 | 325,200 |
| 2012-11-19 | ALXN | Sale | 30,000 | 91.47 | 2,744,100 |
| 2012-06-08 | ALXN | Option Ex | 30,000 | 8.18 | 245,400 |
| 2012-06-08 | ALXN | Sale | 30,000 | 91.01 | 2,730,300 |
| 2012-02-21 | ALXN | Sale | 5,450 | 81.51 | 444,229 |
| 2012-02-03 | ALXN | Option Ex | 3,115 | .00 | 0 |
| 2011-10-31 | ALXN | Option Ex | 6,364 | 4.93 | 31,374 |
| 2011-10-31 | ALXN | Sale | 6,364 | 68.00 | 432,752 |
| 2011-02-17 | ALXN | Sale | 3,965 | 92.45 | 366,564 |
| 2011-02-02 | ALXN | Option Ex | 2,725 | .00 | 0 |
| 2010-11-09 | ALXN | Sale | 11,818 | 72.32 | 854,677 |
| 2010-11-09 | ALXN | Option Ex | 11,818 | 9.87 | 116,643 |
| 2010-08-31 | ALXN | Option Ex | 8,000 | 5.37 | 42,960 |
| 2010-08-31 | ALXN | Sale | 8,000 | 56.72 | 453,760 |
| 2010-02-18 | ALXN | Sale | 5,089 | 48.68 | 247,732 |
| 2010-01-28 | ALXN | Option Ex | 3,965 | .00 | 0 |
| 2009-12-11 | ALXN | Sale | 30,000 | 46.12 | 1,383,600 |
| 2009-12-11 | ALXN | Option Ex | 30,000 | 9.82 | 294,600 |
| 2009-07-27 | ALXN | Sale | 15,000 | 40.06 | 600,900 |
| 2009-07-27 | ALXN | Option Ex | 15,000 | 7.79 | 116,850 |
| 2009-03-10 | ALXN | Sale | 4,000 | 32.78 | 131,120 |
| 2008-08-05 | ALXN | Sale | 9,500 | 91.63 | 870,485 |
| 2008-08-05 | ALXN | Option Ex | 9,500 | 82.38 | 782,562 |
| 2008-06-04 | ALXN | Sale | 6,500 | 70.57 | 458,685 |
| 2008-06-04 | ALXN | Option Ex | 6,500 | 21.76 | 141,440 |
| 2008-02-22 | ALXN | Sale | 2,000 | 61.35 | 122,700 |
| 2007-10-29 | ALXN | Option Ex | 22,000 | 78.92 | 1,736,350 |
| 2006-11-03 | ALXN | Option Ex | 6,400 | 38.49 | 246,316 |
| 2005-10-13 | ALXN | Buy | 1,049 | 26.74 | 28,050 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Parven Alvin S (Director of Alexion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.